CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

Core Insights - CollPlant Biotechnologies is expanding its distribution capabilities in North America by establishing a new logistics center in the U.S. to support its rhCollagen and BioInk product lines [1][3][4] Group 1: Expansion and Infrastructure - The new logistics center will provide cGMP-compliant storage and distribution services, enhancing logistical efficiencies for CollPlant's operations in the U.S. and Canada [1][2] - The facility features advanced infrastructure, including a cloud-based temperature monitoring system, AI-powered security, and remote inventory management, ensuring reliable and secure distribution [2] Group 2: Strategic Commitment - The establishment of the U.S. logistics center reflects CollPlant's long-term commitment to the North American market and is seen as a significant milestone in advancing its regenerative medicine products [3] - By maintaining local inventory, the company aims to improve efficiency and reduce shipping times, thereby enhancing customer access to its products [3] Group 3: Company Overview - CollPlant focuses on regenerative and aesthetic medicine, utilizing its proprietary recombinant human collagen technology for various applications, including tissue repair and organ manufacturing [4] - The company has previously entered into a global commercialization agreement for dermal and soft tissue fillers with Allergan, a leader in the dermal filler market [5]